AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15812256
Drug: Valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 160 mg od + Hydrochlorothiazide 25 mg
Trial: 6870216
Drug: Intranasal enviroxime,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal enviroxime, given 6 times a day
Trial: 6870216
Drug: Intranasal enviroxime
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal enviroxime (in volunteers without symptoms at the start of medication)
Trial: 23185762
Drug: Yiqi Huoxue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yiqi Huoxue Qufeng Decoction (YHQD), one dose daily, once in the morning and once in the evening for 8 weeks
Trial: 23185762
Drug: Fuyang Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuyang Granule (FYG), 6 g each time, three times daily for 8 weeks
Trial: 15675986
Drug: L3/4T group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L3/4T group (4 mg hyperbaric bupivacaine, head-down tilt)
Trial: 15675986
Drug: L2/3 group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L2/3 group (4 mg hyperbaric bupivacaine, horizontal)
Trial: 15675986
Drug: L3/4H group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L3/4H group (4 mg hyperbaric bupivacaine, horizontal)
Trial: 17326150
Drug: Lactulose treatment
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose treatment for 3 months (n=31)
Trial: 17326150
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group, n=30)
Trial: 30146446
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (0.9% sodium chloride)
Trial: 7979616
Drug: Preoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiation therapy (500 cGy)
Trial: 7979616
Drug: No preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preoperative therapy
Trial: 3055924
Drug: Nifedipine-propranolol combination
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine-propranolol combination therapy
Trial: 3055924
Drug: Diltiazem-propranolol combination
RxNorm normalized name: propranolol and other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem-propranolol combination therapy
Trial: 4808815
Drug: Long-term aspirin
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term aspirin and prednisone (patients)
Trial: 25155895
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy monitoring (DTMG)
Trial: 21477065
Drug: GMP (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GMP (1 or 2 mg glimepiride, 500 mg sustained-release metformin, and 15 mg pioglitazone administered once daily)
Trial: 21477065
Drug: IM (human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM (human insulin 70/30 mix and 500 mg sustained-release metformin administered twice daily)
Trial: 18094223
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate hydrofluoroalkane 88 mug twice a day
Trial: 18094223
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate chlorofluorocarbon 88 mug twice a day
Trial: 6086466
Drug: WHO recommended
RxNorm normalized name: ALCOHOL 80 mL in 100 mL TOPICAL LIQUID [WHO Recommended Hand Rub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO recommended oral rehydration solution containing 2.5 g sodium bicarbonate per litre
Trial: 6086466
Drug: Both sodium
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both sodium citrate and sodium bicarbonate solutions
Trial: 21770835
Drug: Early high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early high doses parenteral nutrition (3.0 g/kg/day amino acids and 3 g/kg/day of 20% lipid)
Trial: 21770835
Drug: Early low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early low dose parenteral nutrition (1 g/kg/day amino acids and lipid, advanced to 3 g/kg/day over 3 days)
Trial: 11897906
Drug: Antiphospholipid antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiphospholipid antibodies (aPL) presence in women undergoing IVF‐ET
Trial: 9834049
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg oral ibuprofen 30 minutes before surgery
Trial: 8077892
Drug: Antacid solution
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid solution
Trial: 15864218
Drug: l-NMMA (NO-synthase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-NMMA (NO-synthase inhibitor)
Trial: 16401307
Drug: Cerivastatin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin (0.4 mg/day)
Trial: 10759665
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of ciprofloxacin (500 mg) and tinidazole (600 mg)
Trial: 10759665
Drug: Ciprofloxacin-tinidazole combination
RxNorm normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin-tinidazole combination twice a day for 3 days
Trial: 8628089
Drug: Benzalkonium chloride
RxNorm normalized name: Benzalkonium Chloride
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzalkonium chloride nasal spray
Trial: 1466465
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg morphine sulfate and 100 micrograms epinephrine in normal saline (group 3)
Trial: 26694939
Drug: Ondansetron 4 mg
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg intravenously
Trial: 20200816
Drug: L-methionine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-methionine (0.1 g/kg)
Trial: 18991518
Drug: T'ai chi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T'ai chi (TC) exercise, 90-minute sessions weekly for 9 months
Trial: 17179461
Drug: Antiarrhythmic medications
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic medications
Trial: 9917122
Drug: β-blockers or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blockers or verapamil
Trial: 27464316
Drug: Antidepressant use
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant use
Trial: 20502133
Drug: Tolcapone (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolcapone (as an adjunct to l-dopa)
Trial: 29653649
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg BID
Trial: 24911432
Drug: BID dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BID dosing regimen vs edoxaban QD
Trial: 24911432
Drug: Non-vitamin K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-vitamin K antagonist oral anticoagulants vs warfarin
Trial: 27813398
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg/week
Trial: 15692829
Drug: Theophylline (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (6 mg kg (‐1) body weight) intravenously
Trial: 10215747
Drug: Selegiline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (5 mg, 10 mg, 20 mg, 40 mg) with oral contraceptives
Trial: 10215747
Drug: Selegiline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (5 mg, 10 mg, 20 mg, 40 mg) without oral contraceptives
Trial: 2601986
Drug: Oxybutynin chloride
RxNorm normalized name: Oxybutynin Chloride
DrugBank: Oxybutynin (DB01062)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxybutynin chloride and verapamil combination
Trial: 778564
Drug: Gaviscon (alginate/alginic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gaviscon (alginate/alginic acid plus antacid)
Trial: 204058
Drug: Standard antacid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antacid
Trial: 17145854
Drug: HPV16 L2E7E6
RxNorm normalized name: Recombinant fusion protein of Mycobacterium bovis BCG Hsp65 and HPV16 E7
DrugBank: Verpasep caltespen (DB04959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV16 L2E7E6 vaccine (533-mug) administered thrice at monthly intervals to healthy volunteers
Trial: 11310378
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 g/day for 3 months)
Trial: 8878600
Drug: Oral ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ofloxacin (7.5 mg.kg of body weight‐1 given over 30 min)
Trial: 8878600
Drug: Intravenous ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ofloxacin (7.5 mg.kg of body weight‐1)
Trial: 1725032
Drug: Ramipril monotherapy
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril monotherapy (1.25-10 mg/day)
Trial: 1725032
Drug: Ramipril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (5 mg/day) plus piretanide (3 mg/day)
Trial: 2861527
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg/day)
Trial: 22337680
Drug: Amoxicillin (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (1500 mg/d for 10 days)
Trial: 17906193
Drug: EGCG (Teavigo)
RxNorm normalized name: EGCG
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGCG (Teavigo) 150 mg capsule twice daily
Trial: 7845546
Drug: Atenolol plus
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol plus melatonin (1 mg at 19.30 h and 0.75 mg at 21.00 and 23.00 h)
Trial: 3385910
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone (160 or 320 mg daily)
Trial: 28701493
Drug: Creatine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (40 g daily for up to 48 months)
Trial: 26372412
Drug: Buprenorphine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (20 μg/h) transdermal patch
Trial: 15010695
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal patch
Trial: 19190928
Drug: 600 microg
RxNorm normalized name: Fentanyl 600 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 microg sublingual misoprostol tablet
Trial: 19190928
Drug: 600 microg
RxNorm normalized name: Fentanyl 600 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 microg powdery sublingual misoprostol
Trial: 18650545
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg/day for 4 days
Trial: 17196475
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily for 3 days
Trial: 3233185
Drug: Topical administration
RxNorm normalized name: Octocaine 5 % Ointment for Oral and Topical Administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical administration of RA gel
Trial: 28481883
Drug: TV003 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TV003 vaccine (live attenuated tetravalent dengue vaccine)
Trial: 21521683
Drug: Routine sedative
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine sedative protocol (Midazolam and fentanyl) (group M)
Trial: 15029143
Drug: Captopril (37.5‐150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (37.5‐150 mg, average dose 72+/‐34.2 mg/day)
Trial: 15029143
Drug: Eprosartan (300‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (300‐600 mg, average dose 471+/‐151 mg/day)
Trial: 22926853
Drug: Placebo (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (as an add-on therapy to methylprednisolone)
Trial: 20730705
Drug: Diane (35)
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane (35) Diario contraceptive pill (35 μg of ethynylestradiol plus 2 mg of cyproterone acetate)
Trial: 16112085
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and paclitaxel treatment in patients with valine homozygotic genotype
Trial: 16112085
Drug: Cisplatin and
RxNorm normalized name: A micelle drug formulation composed of cisplatin and mPEG-poly(l-Glu) diblock copolymer with 1,3-propanediyl linkagecisplatin is incorporated in polymeric micelles via polymer-metal complex formation with cis-geometry of PT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin and paclitaxel treatment in patients with G allele
Trial: 10331327
Drug: Prelone (Muro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prelone (Muro Pharmaceuticals, Tewksbury, MA)
Trial: 10331327
Drug: Prednisone 10‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 10‐mg tablet crushed in 10 mL of cherry syrup
Trial: 9112163
Drug: Sublingual administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual administration of 20 microliters of 0.5% timolol solution
Trial: 9112163
Drug: Unilateral ocular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral ocular administration of 20 microliters of 0.5% timolol solution
Trial: 1745711
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g sugar with alcohol
Trial: 1745711
Drug: 35 g
RxNorm normalized name: SODIUM CHLORIDE 0.135 g in 15 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 g sugar with alcohol
Trial: 28967351
Drug: LSD (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LSD (100 µg)
Trial: 31500679
Drug: Ketanserin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (40 mg) pretreatment with LSD
Trial: 42487
Drug: Timolol (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (multiple doses)
Trial: 42487
Drug: Timolol (twice-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (twice-daily schedule)
Trial: 42487
Drug: Timolol (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (single oral doses)
Trial: 31771436
Drug: Ketofol (1:3)
RxNorm normalized name: Ketozole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketofol (1:3) - low-dose ketamine 0.15 mg/kg followed by propofol 0.45 mg/kg i.v.
Trial: 23371895
Drug: TXA loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA loading dose of 50 mg/kg over 15 min followed by a 5 mg/kg/h maintenance infusion during surgery
Trial: 23371895
Drug: Simulated loading
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated loading dose of 10 mg/kg over 15 min followed by a 5 mg/kg/h maintenance infusion
Trial: 7268333
Drug: Lillehei‐Kaster (L‐K)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lillehei‐Kaster (L‐K) valves
Trial: 29726739
Drug: 80-mg ixekizumab
RxNorm normalized name: ixekizumab 80 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80-mg ixekizumab every 2 weeks (IXEQ2W)
Trial: 29726739
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg etanercept (ETN) biweekly
Trial: 29726739
Drug: 80-mg ixekizumab
RxNorm normalized name: ixekizumab 80 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80-mg ixekizumab every 4 weeks (IXEQ4W)
Trial: 22690320
Drug: WGOE supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WGOE supplementation (1500 mg/day)
Trial: 19304577
Drug: Larval therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Larval therapy (loose or bagged larvae)
Trial: 26504153
Drug: Exemestane (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane (25 mg)
Trial: 25137428
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg)
Trial: 11280847
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of zidovudine (AZT)
Trial: 11280847
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of zidovudine (AZT)
Trial: 1409765
Drug: Harpagophytum procumbens
RxNorm normalized name: Harpagophytum procumbens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Harpagophytum procumbens (Devil's Claw) - 4 capsules of 500 mg powder containing 3% total glucoiridoids daily for 21 days
Trial: 2417351
Drug: Heparin (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (loading dose 2,500 IU + continuous infusion of 1,800 IU/hr)
Trial: 2417351
Drug: Both Org
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both Org 10172 and Heparin
Trial: 30324927
Drug: Oral dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexmedetomidine
Trial: 16036196
Drug: Sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine (group A)
Trial: 8665534
Drug: Entacapone (100-800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (100-800 mg)
Trial: 8665534
Drug: Entacapone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (400 mg and 800 mg)
Trial: 8665534
Drug: CR levodopa-carbidopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR levodopa-carbidopa without entacapone (control treatment)
Trial: 6355798
Drug: Hypertransfusion (red
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertransfusion (red cell transfusion to a hemoglobin value ≥ 17 gm/dl prior to each chemotherapy cycle)
Trial: 26724671
Drug: Reduced dose
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced dose X-ray examination (3.06 μSv)
Trial: 26724671
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose X-ray examination (4.57 μSv)
Trial: 26724671
Drug: Evaluation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evaluation of defined criteria (dose-independent)
Trial: 9883710
Drug: HCTZ (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCTZ (12.5 mg or 25 mg) alone
Trial: 7976233
Drug: Tolfenamic acid
RxNorm normalized name: Tolfenamic acid
DrugBank: Tolfenamic acid (DB09216)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolfenamic acid 100 mg three times daily
Trial: 2227221
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg three times daily
Trial: 25811573
Drug: Silicone gel
RxNorm normalized name: SILTREX Silicone Gel-Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone gel sheets for 6 months
Trial: 12011552
Drug: Short (3-day)
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short (3-day) hospitalization followed by home care treatment
Trial: 2185967
Drug: Octreotide infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide infusion (25 micrograms/h)
Trial: 16290290
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atorvastatin for 6 weeks
Trial: 11579113
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no adjuvant therapy)
Trial: 10506720
Drug: Carbogen inhalation
RxNorm normalized name: carbogen Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbogen inhalation alone
Trial: 10506720
Drug: Carbogen inhalation
RxNorm normalized name: carbogen Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbogen inhalation with oral nicotinamide (80 mg/kg)
Trial: 7554702
Drug: Alendronate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (5 to 80 mg) taken with water in the fasting state
Trial: 7554702
Drug: Alendronate with
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate with ranitidine infusion to increase gastric pH
Trial: 24252703
Drug: AS03A-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03A-adjuvanted vaccine (3.75 μg hemagglutinin)
Trial: 24252703
Drug: AS03B-adjuvanted vaccine
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03B-adjuvanted vaccine (1.9 μg hemagglutinin, one or two doses)
Trial: 21983354
Drug: All study
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All study vaccines